Search hospitals > Virginia > Fairfax
Virginia Cancer Specialists
Claim this profileFairfax, Virginia 22031
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Solid Tumors
Conducts research for Tumors
Conducts research for Cancer
Conducts research for Lung Cancer
440 reported clinical trials
19 medical researchers
Summary
Virginia Cancer Specialists is a medical facility located in Fairfax, Virginia. This center is recognized for care of Non-Small Cell Lung Cancer, Solid Tumors, Tumors, Cancer, Lung Cancer and other specialties. Virginia Cancer Specialists is involved with conducting 440 clinical trials across 250 conditions. There are 19 research doctors associated with this hospital, such as Alexander Spira, MD, Alex Spira, MD, PhD, Mitul Gandhi, and Anne Favret, MD.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
2Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Alexander Spira, MDVirginia Cancer Specialists2 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Tumors
124 reported clinical trials
166 drugs studied
Alex Spira, MD, PhDNEXT Oncology4 years of reported clinical research
Expert in Solid Tumors
Studies Non-Small Cell Lung Cancer
21 reported clinical trials
32 drugs studied
Mitul GandhiVirginia Cancer Specialists2 years of reported clinical research
Studies Lymphoma
Studies Leukemia
17 reported clinical trials
31 drugs studied
Anne Favret, MDVirginia Cancer Specialists, PC3 years of reported clinical research
Studies Breast Cancer
Studies Tumors
4 reported clinical trials
10 drugs studied
Clinical Trials running at Virginia Cancer Specialists
Solid Tumors
Tumors
Non-Small Cell Lung Cancer
Breast Cancer
Prostate Cancer
Pancreatic Cancer
Lung Cancer
Cancer
Colorectal Cancer
Ovarian Cancer
CFI-402257 + Fulvestrant
for Breast Cancer
This trial tests a new drug, CFI-402257, alone and with Fulvestrant in patients with advanced solid tumors and advanced breast cancer. It aims to determine if the drug is safe and effective by studying its effects on the body and cancer cells. Fulvestrant is an established treatment for hormone receptor-positive advanced breast cancer, often used in combination with other therapies to improve outcomes.
Recruiting3 awards Phase 1 & 23 criteria
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting3 awards Phase 1 & 221 criteria
T3011 + Pembrolizumab
for Solid Cancers
This is a Phase 1/2a, open-label, study to evaluate the safety and preliminary efficacy of intratumoral T3011 given alone and in combination with intravenous pembrolizumab in partients with advanced or metastatic solid tumors.
Recruiting2 awards Phase 1 & 214 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Virginia Cancer Specialists?
Virginia Cancer Specialists is a medical facility located in Fairfax, Virginia. This center is recognized for care of Non-Small Cell Lung Cancer, Solid Tumors, Tumors, Cancer, Lung Cancer and other specialties. Virginia Cancer Specialists is involved with conducting 440 clinical trials across 250 conditions. There are 19 research doctors associated with this hospital, such as Alexander Spira, MD, Alex Spira, MD, PhD, Mitul Gandhi, and Anne Favret, MD.
Where is Virginia Cancer Specialists located?
Virginia Cancer Specialists is located at 8613 Lee Highway, Fairfax, VA 22031.
Who should I call to ask about financial aid or insurance network?
Virginia Cancer Specialists offers comprehensive financial assistance for patients dealing with insurance and billing concerns. Patients can seek help from a Patient Benefit Specialist at their physician's location for insurance inquiries and verifications, or contact Patient Benefits Representatives (PBR) at Virginia Oncology Associates (VOA) locations for guidance on financial issues and assistance programs. For general insurance questions, the insurance coverage page on their website provides a list of accepted insurance companies, with additional coverage options available upon inquiry at the physician's office.
What insurance does Virginia Cancer Specialists accept?
**Virginia Cancer Specialists Insurance Information:**
- Accepts a wide range of insurance plans including but not limited to Aetna US Healthcare, Anthem Blue Cross Blue Shield, Blue Cross Blue Shield North Carolina, CIGNA, Coventry Health Care, and United Healthcare.
- Patients are advised to confirm their insurance plan's participation and be aware of their responsibilities like obtaining referrals and paying copayments, coinsurance, or deductibles.
**Virginia Cancer Institute Insurance Information:**
- Participates with many insurance plans in Central Virginia, with a commitment to staying informed on the changing medical insurance landscape.
- Encourages patients to verify their insurance details and is prepared to assist with insurance queries.
What awards or recognition has Virginia Cancer Specialists received?
Virginia Cancer Specialists (VCS) has been re-accredited for the prestigious Accreditation Program for Excellence (APEx) distinction in 2022, showcasing its excellence in cancer care. It received the Clinical Trials Participation Award in 2016, highlighting its commitment to advancing cancer care through community-based clinical trials. The VCS Research Institute is recognized for its outstanding research program and efficient study start-up timelines.